A study compared the association of semaglutide vs other antidiabetic medications and other GLP-1RAs, including liraglutide ...

Novo Nordisk CEO Lars Fruergaard Jorgensen testified before the Senate Health, Education, Labor and Pensions Committee hearing in ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

Novo Nordisk, the makers of Wegovy, recently announced the phase 1 trial results of a new oral weight loss pill they're ...